Magnesium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulfate is an essential mineral that plays a crucial role in numerous biochemical functions. It is available for intravenous, intramuscular, and oral administration. ## Primary Indications * **Hypomagnesemia:** Treatment of confirmed magnesium deficiency. * **Eclampsia and Preeclampsia:** Prevention and treatment of seizures associated with severe preeclampsia and eclampsia. * **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia in the setting of hypomagnesemia. * **Bronchodilation:** Adjunctive therapy for severe asthma exacerbations. * **Constipation (Oral):** Osmotic laxative. ## Adult Dosing Dosing varies significantly based on indication and severity. * **Hypomagnesemia (Symptomatic/Severe):** * **Initial IV dose:** 4-6 grams IV over 5-60 minutes, followed by 1-2 grams per hour by continuous infusion. * **IM dose:** 1 gram IM every 4 hours as needed (no more than 4 doses in 24 hours). * *Specific infusion rates and total daily doses may vary based on local protocol and magnesium levels.* * **Eclampsia/Preeclampsia:** * **Loading dose:** 4-6 grams IV, infused over 5 minutes. * **Maintenance infusion:** 1-2 grams per hour. * *Dosing is often guided by specific hospital protocols.* * **Torsades de Pointes:** * **Initial IV dose:** 1-2 grams IV diluted in 10-20 mL D5W over 5-10 minutes. * **Continuous infusion:** 0.5-1 gram per hour. * **Asthma (Severe):** * 1-2 grams IV as a single dose over 15-30 minutes. * **Constipation (Oral):** * 10-30 grams orally once daily. ## Pediatric Dosing Dosing for pediatric patients is weight-based and often guided by specific protocols. * **Hypomagnesemia:** * **IV infusion:** 25-50 mg/kg/dose (equivalent to 0.1-0.2 mmol/kg/dose) over 10-60 minutes. May repeat every 4-12 hours. Maintenance infusion: 0.1-0.5 mmol/kg/hour. * **Eclampsia:** Dosing for pediatric patients with eclampsia is less well-established and is typically managed by specialists. * **Asthma:** * **IV infusion:** 25-40 mg/kg/dose (equivalent to 0.1-0.16 mmol/kg/dose) over 15-30 minutes. Maximum dose is typically 2 grams. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. In patients with impaired renal function, doses should be reduced and serum magnesium levels closely monitored. ## Contraindications * Hypermagnesemia. * Heart block. * Myocardial infarction (in certain situations). * Hypertrophic obstructive cardiomyopathy. * Hypersensitivity to magnesium sulfate. ## Adverse Effects * **Common:** Flushing, warmth, hypotension, nausea, vomiting, diaphoresis, drowsiness, decreased deep tendon reflexes. * **Serious:** Respiratory depression, cardiac arrest, hypermagnesemia (muscle weakness, loss of deep tendon reflexes, ECG changes, bradycardia, hypotension, respiratory depression, cardiac arrest). ## Key Drug Interactions * **Neuromuscular Blockers:** Magnesium can potentiate the neuromuscular blocking effects of drugs like rocuronium, vecuronium, and succinylcholine, potentially leading to prolonged paralysis. * **Calcium Channel Blockers:** Additive hypotensive effects and potential for cardiac arrhythmias. * **Antibiotics:** May interfere with the absorption of tetracyclines and fluoroquinolones when given concurrently orally. ## Monitoring * **Serum Magnesium Levels:** Essential, especially with IV infusions, renal impairment, or prolonged therapy. Target levels vary by indication. * **Renal Function:** Monitor BUN and creatinine. * **Vital Signs:** Blood pressure, heart rate, respiratory rate. * **Deep Tendon Reflexes:** Loss of reflexes is an early sign of toxicity. * **Urine Output:** Adequate renal function is crucial for magnesium excretion. * **ECG:** Particularly in cases of suspected toxicity or cardiac indications. ## Clinical Pearls * Always confirm the concentration of magnesium sulfate solutions before administration, especially for IV infusions. * IV magnesium sulfate administration can cause transient flushing and warmth; infuse slowly to minimize these effects. * In patients with impaired renal function, use with extreme caution and monitor magnesium levels closely. * Discontinue infusion if signs of magnesium toxicity (e.g., loss of deep tendon reflexes, decreased respiratory rate) occur. Calcium gluconate is the antidote for severe toxicity. *** **Disclaimer:** This information is intended for clinical professionals. It is essential to consult the most current official prescribing information and relevant clinical guidelines for complete and up-to-date details before making any treatment decisions. Drug information can change rapidly.